Search Ontology:
ChEBI

cyproheptadine

Term ID
CHEBI:4046
Synonyms
  • 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine
  • 1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine
  • 4-(5-dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine
  • 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine
  • 4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine
  • 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine
  • 4-Dibenzo[a,d]cyclohepten-5-ylidene-1-methyl-piperidine
  • 5-(1-methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene
  • ciproheptadina
  • CYPROHEPTADINE
  • cyproheptadinum
Definition
The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
References
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
is a type of
has_role
inverse has_part
Phenotype
Phenotype resulting from cyproheptadine
Phenotype where environments contain cyproheptadine
Phenotype modified by environments containing cyproheptadine
Human Disease Model